Ligand Pharmaceuticals Acquires Icagen - Core Assets, Partnered Programs And ION Channel Technologies
Ligand Pharmaceuticals acquired Icagen - Core Assets, Partnered Programs And ION Channel Technologies for $15.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Ligand Pharmaceuticals
- Acquired Company
- Icagen - Core Assets, Partnered Programs And ION Channel Technologies
- Price
- $15.0M
- Acquisition Type
- Acquisition
- Announced
- February 11, 2020
Canonical: https://fsome.com/acquisitions/ligand-pharmaceuticals-acquires-icagen-core-assets-partnered-programs-and-ion-channel-technologies-8093642 · For the full deal terms, timeline, and press references, please enable JavaScript.